ロード中...
Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose
Synthetic glucocorticoids (GCs) are widely used in the variety of dosages for treatment of premature infants with chronic lung disease, respiratory distress syndrome, allergies, asthma, and other inflammatory and autoimmune conditions. Yet, adverse effects such as glucocorticoid-induced osteoporosis...
保存先:
| 出版年: | Exp Biol Med (Maywood) |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5363691/ https://ncbi.nlm.nih.gov/pubmed/28178857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370217693322 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|